Neuros recently received an investigational device exemption from the FDA to evaluate its chronic pain management system, the electrical nerve block, for use in amputee patients to manage pain in the residual limb.
Neuravi successfully completes Series A financing
Irish medical device company Neuravi Limited successfully completed a Series A financing round for $6.5 million (€5.2 million).
E.U. biotech quartet wins $5.2M for artificial liver research
A group of European biotechnology developers won $5.2 million (€4.2 million) to advance their collaborative work on artificial liver tissue.
Say hello to MassDevice +7, a bite-sized view of the top seven med-tech stories of the week. This latest feature of MassDevice.com’s coverage highlights our seven biggest and most influential stories from the week’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else this weekend, make sure you’re still in the know with MassDevice +7.
Eye care goliath Bausch & Lomb may be looking to go public this year, a move that would signal renewed confidence in the company following a bit of a rough patch.
Bausch was taken private in 2007 by Warburg Pincus for $4.5 billion after accounting discrepancies forced the company to restate its earnings and contaminated contact disinfectant solution resulted in a high-profile recall.
Novation said members of VHA Inc., UHC and Provista LLC can nab discounts of up to 71% on capital equipment fromJuly through September.
The group purchasing organization said the discounts include medical devices ranging from centrifuges and patient beds to CT scanners and nuclear medicine equipment.
Cohera Medical’s Series D tops $8M
Pittsburgh-based Cohera Medical raised more than $8.4 million in its Series D round, the funds from which will go toward expanding commercialization of its lead TissuGlu surgical adhesive in markets in Europe.
Benvenue Medical raised $25 million in a Series D round of financing, planning to use the funds to penetrate the $9 billion global spine device market with support for commercialization in the U.S. and abroad.
The privately held spinal devices maker, launched in 2004, said it’s "well-poised for rapid U.S. and global sales" of its trio of minimally invasive surgical and interventional products for treatment of degenerative disc disease and vertebral compression fractures.
San Francisco-based startup Practice Fusion raised $34 million in its latest Series C funding round in support of its free online electronic medical record service, which the company says represents the largest physician-patient community in the U.S.